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Extensive epidemiological studies investigating Down’s
syndrome have shown an association between cancer and
Down’s syndrome (1-3). The most common cancers seen
in children with Down’s syndrome are acute leukemias.
Myelodysplastic syndrome is a rare hematological
disorder in childhood, which can lead to acute leukemia.

typical symtoms of Down’s syndrome such as upslanting
palpebral fissures, hypertelorism, depressed nasal bridge,
geographical tongue, high-arched palate, dental
malocclusion, simian creases and clinodactyly in the
hands. The liver and spleen were 3 cm and 2 cm the
costal margin, respectively.

In this paper, we report on a child with Down’s
syndrome who was diagnosed as having myelodysplastic
syndrome. He also has Robertsonian translocation
between chromosome 13 and 14(t(13q;14q)), inherited
from the mother.

Laboratory tests revealed profound anemia (Hb: 5.9
gm/dl, Hct: 21.9%, MCV: 79), leukopenia (1900/mm3 ),
trombocytopenia (90 000/mm3 ). The distribution of
peripheral blood cells was normal for his age group. The
eryrocyte sedimentation rate, blood electrolytes, liver
function tests, thyroid function tests and ECG were
normal. Serum iron and iron binding capacity were found
to be 25 gamma, and 308 gamma, respectively. Both of
them showed iron-deficiency anemia. The serum ferritin
level was lower than normal, 3 ng/ml. Bone marrow
aspiration and biopsy showed hypercellularity and
micromegakaryocytosis. No abnormality was observed in
the examination of bone marrow with cytochemical stain
for iron. Karyotyping studies revealed that the patient has
46,XY, t(13;14), +21(Fig.1) and the mother and one of
the siblings were the carries of t(13;14).

H.Ö., a 14-year-old boy, was the ninth child of the
family. When he was born his mother was 22 years old.
She had had four previous abortions and four previous
healthy children. The pregnancy and delivery occurred
without complications. In the newborn period, by clinical
findings he was diagnosed as having Down’s syndrome.
His motor and mental development were retarded. One
and a half years ago he was examined by the hematology
department of another hospital for his pallid appearance
and fatigue. During that period his CBC showed anemia
and mild leukopenia (2800/mm3 ). The cause of anemia
was considered to be nutritional deficency because of the
low levels of serum iron and ferritin. He was given iron
orally but his anemia did not respond to therapy for
several months. Subsequent CBCs performed at monthly
intervals for one year showed refractory anemia,
leukopenia and trombocytopenia. During that year bone
marrow examinations showed hypercellularity in all series
of cells. He was referred to our hospital for further
examination.
On admission his weight was 35 kg (25th-50th
centile), height 142 cm (25th-50th centile), head
circumference 50 cm (10th-25th centile). He had the

According to the FAB classification, myelodysplastic
syndromes have five categories: refractory anemia (RA),
refractory anemia with ringed sideroblast (RARS),
refractory anemia with excess blasts (RAEB), refractory
anemia with excess blasts in transformation (RAEB-t) and
chronic myelomonocytic leukemia (CMML). The
syndromes are most common in patients over 50 and are
quite rare in childhood (4). In patients with
myelodysplastic syndrome, peripheral blood tests show
the symptoms of bone marrow failure such as anemia,
neutrophenia and/or thrombocytopenia. However, bone
marrow cellularity is usually normal to increased.
Excessive reticulin is present in most cases (4).
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Figure 1.

The patient discussed here was diagnosed as having
first category myelodysplastic syndrome in addition to
Down’s syndrome. He had the typical peripheral blood
counts and bone marrow findings for myelodysplastic
syndrome. Despite his refractory anemia he had
hypercellular bone marrow. This is an example of relative
bone marrow failure, which is one of the characteristics
of myelodysplastic syndrome (4). Micromegakaryocytic
changes are also common in myelodysplastic syndrome.
Megakaryoctic changes may be in size, nuclear to
cytoplasmic ratio and nuclei (4). In our patient
micromegakaryocytosis was observed. There were no
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Karyotyping of pationt.

ringed sideroblasts or blastic transformations which
indicate a more progressive form of myelodysplastic
syndrome in bone marrow examination.
Nair et al. reported on 16 children with
myelodysplastic syndrome, one of which had regular
Down’s syndrome (5). Homans et al. described a unique
myelodysplastic syndrome in children with Down’s
syndrome (6). In their study of 95 children, 27% of the
patients died, 33% of the patients developed subsequent
hematological disorders, most often acute leukemias (5).
Leukemic transformation, however, is not inevitable,
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myelodysplastic syndromes are usually classified as
preleukemic (4). Although the frequencies of leukemias
are different in different studies, megakaryoblastic
leukemia (M7) is much more common in children with
Down’s syndrome than in normal children (7, 8, 9, 10).
In our study micromegakaryocytosis found in bone
marrow may be one of the signs of myelodysplastic
syndrome.
Karyotping studies of the patient (Figure 1), his
mother and one of his siblings exhibited t(13;14). A
number of cases with the same circumstances have been
reported (11, 12). Whether the balanced Robertsonian
translocations make the child predisposed to Down’s
syndrome is controversial. In our opinion, the case

presented here, would appear to support this hypothesis.
Although our case has two different types of
chromosomal abnormality, we believe that trisomy 21 is
the causative factor and t(13;14), found in our patient,
we consider to be a coincidental chromosomal
abbreviation. To our knowledge no cases have been
reported showing t(13;14) in conjuction with
myelodysplastic syndrome. However many cases have
been reported with both hematological abnormalities and
trisomy 21.
Correspendence author:
Ferda ÖZKINAY
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